FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2310313429> ?p ?o ?g. }

• W2310313429 endingPage "90" @default.
• W2310313429 startingPage "85" @default.
• W2310313429 abstract "<h3>Objectives</h3> Biosimilar infliximab, the first similar biological medicinal product containing monoclonal antibodies to be commercialised, is likely to contribute to a significant reduction in healthcare costs. We aimed to assess the cost savings potential over 1 year of the use of biosimilar infliximab for the treatment of rheumatoid arthritis (RA) patients in Alsace and in France, in a real-life setting. <h3>Methods</h3> The analysis was based on a previously conducted observational study which evaluated the annual cost of the care of patients with RA treated with biological therapies in 2012 in Alsace. Average annual costs to manage RA patients were calculated, taking into account the decrease in the retail price between 2012 and 2015 (as given in the official national price list) and the local negotiated price for biosimilar infliximab. Annual cost savings for different biosimilar prescription scenarios were calculated using 2015 prices. <h3>Results</h3> Management of RA patients with biosimilar infliximab was significantly cheaper than with adalimumab or etanercept (€11 907 vs €12 981 and €13 551, respectively). The projected annual cost savings reached €13.6 million nationally, if all adult RA patients treated with the originator infliximab switched to the biosimilar drug. These savings, if fully reallocated for the treatment of RA, would enable the treatment of 1141 additional patients. <h3>Conclusions</h3> The study showed a positive financial impact of introducing biosimilar infliximab for the treatment of RA patients in France. Such savings could contribute to improved patient care by allowing more patients to be treated without more money being spent." @default.
• W2310313429 created "2016-06-24" @default.
• W2310313429 creator A5027885279 @default.
• W2310313429 creator A5035094985 @default.
• W2310313429 creator A5053984097 @default.
• W2310313429 creator A5061496445 @default.
• W2310313429 creator A5080881858 @default.
• W2310313429 creator A5081861523 @default.
• W2310313429 date "2016-03-24" @default.
• W2310313429 modified "2023-10-18" @default.
• W2310313429 title "Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?" @default.
• W2310313429 cites W1251997985 @default.
• W2310313429 cites W1556890549 @default.
• W2310313429 cites W1761300068 @default.
• W2310313429 cites W1971471395 @default.
• W2310313429 cites W1979502053 @default.
• W2310313429 cites W1981336058 @default.
• W2310313429 cites W1993762334 @default.
• W2310313429 cites W2032836693 @default.
• W2310313429 cites W2057687448 @default.
• W2310313429 cites W2060549798 @default.
• W2310313429 cites W2093884168 @default.
• W2310313429 cites W2096103877 @default.
• W2310313429 cites W2109176553 @default.
• W2310313429 cites W2110327661 @default.
• W2310313429 cites W2113633952 @default.
• W2310313429 cites W2119138901 @default.
• W2310313429 cites W2120393706 @default.
• W2310313429 cites W2121050884 @default.
• W2310313429 cites W2123854456 @default.
• W2310313429 cites W2137961216 @default.
• W2310313429 cites W2158003651 @default.
• W2310313429 cites W253009427 @default.
• W2310313429 cites W4210768724 @default.
• W2310313429 cites W990700033 @default.
• W2310313429 doi "https://doi.org/10.1136/ejhpharm-2016-000904" @default.
• W2310313429 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6451627" @default.
• W2310313429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31156910" @default.
• W2310313429 hasPublicationYear "2016" @default.
• W2310313429 type Work @default.
• W2310313429 sameAs 2310313429 @default.
• W2310313429 citedByCount "8" @default.
• W2310313429 countsByYear W23103134292016 @default.
• W2310313429 countsByYear W23103134292017 @default.
• W2310313429 countsByYear W23103134292019 @default.
• W2310313429 countsByYear W23103134292022 @default.
• W2310313429 countsByYear W23103134292023 @default.
• W2310313429 crossrefType "journal-article" @default.
• W2310313429 hasAuthorship W2310313429A5027885279 @default.
• W2310313429 hasAuthorship W2310313429A5035094985 @default.
• W2310313429 hasAuthorship W2310313429A5053984097 @default.
• W2310313429 hasAuthorship W2310313429A5061496445 @default.
• W2310313429 hasAuthorship W2310313429A5080881858 @default.
• W2310313429 hasAuthorship W2310313429A5081861523 @default.
• W2310313429 hasBestOaLocation W23103134291 @default.
• W2310313429 hasConcept C126322002 @default.
• W2310313429 hasConcept C160735492 @default.
• W2310313429 hasConcept C162324750 @default.
• W2310313429 hasConcept C23131810 @default.
• W2310313429 hasConcept C2426938 @default.
• W2310313429 hasConcept C2777138892 @default.
• W2310313429 hasConcept C2777226972 @default.
• W2310313429 hasConcept C2777575956 @default.
• W2310313429 hasConcept C2779134260 @default.
• W2310313429 hasConcept C2780132546 @default.
• W2310313429 hasConcept C50522688 @default.
• W2310313429 hasConcept C59491497 @default.
• W2310313429 hasConcept C71924100 @default.
• W2310313429 hasConcept C98274493 @default.
• W2310313429 hasConceptScore W2310313429C126322002 @default.
• W2310313429 hasConceptScore W2310313429C160735492 @default.
• W2310313429 hasConceptScore W2310313429C162324750 @default.
• W2310313429 hasConceptScore W2310313429C23131810 @default.
• W2310313429 hasConceptScore W2310313429C2426938 @default.
• W2310313429 hasConceptScore W2310313429C2777138892 @default.
• W2310313429 hasConceptScore W2310313429C2777226972 @default.
• W2310313429 hasConceptScore W2310313429C2777575956 @default.
• W2310313429 hasConceptScore W2310313429C2779134260 @default.
• W2310313429 hasConceptScore W2310313429C2780132546 @default.
• W2310313429 hasConceptScore W2310313429C50522688 @default.
• W2310313429 hasConceptScore W2310313429C59491497 @default.
• W2310313429 hasConceptScore W2310313429C71924100 @default.
• W2310313429 hasConceptScore W2310313429C98274493 @default.
• W2310313429 hasIssue "2" @default.
• W2310313429 hasLocation W23103134291 @default.
• W2310313429 hasLocation W23103134292 @default.
• W2310313429 hasLocation W23103134293 @default.
• W2310313429 hasLocation W23103134294 @default.
• W2310313429 hasOpenAccess W2310313429 @default.
• W2310313429 hasPrimaryLocation W23103134291 @default.
• W2310313429 hasRelatedWork W1616520369 @default.
• W2310313429 hasRelatedWork W1973470095 @default.
• W2310313429 hasRelatedWork W1976481621 @default.
• W2310313429 hasRelatedWork W1993992685 @default.
• W2310313429 hasRelatedWork W2000233941 @default.
• W2310313429 hasRelatedWork W2396704791 @default.
• W2310313429 hasRelatedWork W2552627355 @default.
• W2310313429 hasRelatedWork W2738087986 @default.

• next